ALLO - Allogene Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ALLO is currently covered by 12 analysts with an average price target of $10.87. This is a potential upside of $9.69 (821.19%) from yesterday's end of day stock price of $1.18.

Allogene Therapeutics's activity chart (see below) currently has 129 price targets and 127 ratings on display. The stock rating distribution of ALLO is 82.35% BUY and 17.65% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 22.74% with an average time for these price targets to be met of 78.4 days.

Highest price target for ALLO is $14, Lowest price target is $7, average price target is $9.07.

Most recent stock forecast was given by BRIAN CHENG from JPMORGAN on 04-Aug-2025. First documented stock forecast 05-Nov-2018.

Currently out of the existing stock ratings of ALLO, 28 are a BUY (82.35%), 6 are a HOLD (17.65%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$8

24 days ago
(04-Aug-2025)

0/3 (0%)

$2.86 (55.64%)

Hold

$5

24 days ago
(04-Aug-2025)

1/9 (11.11%)

$3.06 (157.73%)

148

Buy

$10

$8.81 (740.34%)

3 months 14 days ago
(14-May-2025)

2/10 (20%)

$9.05 (952.63%)

94

Buy

$9

$7.81 (656.30%)

$10

3 months 14 days ago
(14-May-2025)

0/3 (0%)

$8.05 (847.37%)

Buy

$7

$5.81 (488.24%)

$9

3 months 14 days ago
(14-May-2025)

2/9 (22.22%)

$6.05 (636.84%)

3

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ALLO (Allogene Therapeutics) average time for price targets to be met?

On average it took 78.4 days on average for the stock forecasts to be realized with a an average price target met ratio 22.74

Which analyst has the current highest performing score on ALLO (Allogene Therapeutics) with a proven track record?

MARK BREIDENBACH

Which analyst has the most public recommendations on ALLO (Allogene Therapeutics)?

Mark Breidenbach has 1 price targets and 6 ratings on ALLO

Which analyst is the currently most bullish on ALLO (Allogene Therapeutics)?

Luca Issi with highest potential upside - $30.49

Which analyst is the currently most reserved on ALLO (Allogene Therapeutics)?

Dane Leone with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?